THRESHOLD PHARMACEUTICALS, INC...

MKGAF-THLD Unite for Cancer Cure - Analyst Blog

MKGAF-THLD Unite for Cancer Cure

Threshold Pharmaceuticals: Up 150% In 4 Months With Room To Grow

Top Stock Alerts for Day Traders: Human Genome Sciences, DryShips, Alcoa, and Threshold Pharmaceuticals

Morning Movers (SURW, BLRX, THLD, SOHU, ANAC)

Threshold Pharmaceuticals (THLD) Surged To Over An 11-Month High

24/7 Wall St. Closing Bell (MRO, PEET, RIMM, URBN, CHK, GILD, GNW, PCCC, NVLS, PKI, BEAM, EL, WY, THLD, TUDO, ZOLT, STRI, MNKD)

5 Stocks Under $10 Poised for Big Upside

Mid-day Movers (THLD, OPTT, ZNGA, MNOV, MNKD)

Merck KGaA Signs $550 Million Cancer Pact With Threshold Pharmaceuticals, Inc.

Morning Movers (THLD, ZOLT, GNW, STRI, IN)

Threshold Pharma rises 78.3%

Threshold Pharma and Merck KGaA announce global agreement for TH-302

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302

Threshold Pharma management to meet with JMP Securities

Biotech Stock Mailbag: Most Important Events for 2012

When Will Threshold Pharmaceuticals Start To Get Some Respect?

Threshold Pharma announces clinical trial results of Phase 1 TH-302 study

Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias

Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias

Threshold Pharma announces update to TH-302 pancreatic data

Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference

Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference

Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference

Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference

Threshold Pharma TH302 poised to provide catalyst, says JMP Securities

Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q)

Threshold Pharma reports Q3 EPS (8c) vs. consensus (15c)

Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results

Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results

Threshold Pharmaceuticals Appoints Nipun Davar as Vice President of Pharmaceutical Development and Manufacturing

Threshold Pharmaceuticals Appoints Nipun Davar as Vice President of Pharmaceutical Development and Manufacturing

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

Threshold Pharma reports promising data with TH-302 in soft tissue sarcoma

Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma

Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma

Threshold Journey

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference